Literature DB >> 27899052

Initial Response to Transcranial Magnetic Stimulation Treatment for Depression Predicts Subsequent Response.

Michael S Kelly1, Albino J Oliveira-Maia1, Margo Bernstein1, Adam P Stern1, Daniel Z Press1, Alvaro Pascual-Leone1, Aaron D Boes1.   

Abstract

This study provides support for the hypothesis that treatment response to an initial course of repetitive transcranial magnetic stimulation (rTMS) for depression predicts the magnitude of response to a subsequent course of rTMS in the setting of symptom relapse.

Entities:  

Keywords:  Antidepressants; Depression

Mesh：

Year:  2016        PMID： 27899052      PMCID： PMC5592731          DOI： 10.1176/appi.neuropsych.16100181

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  15 in total

1.  Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse.

Authors:  Paul B Fitzgerald; Jessica Benitez; Anthony R de Castella; Timothy L Brown; Z Jeff Daskalakis; Jayashri Kulkarni
Journal:  Aust N Z J Psychiatry       Date:  2006-09       Impact factor: 5.744

2.  The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

Authors:  Paul E Greenberg; Andree-Anne Fournier; Tammy Sisitsky; Crystal T Pike; Ronald C Kessler
Journal:  J Clin Psychiatry       Date:  2015-02       Impact factor: 4.384

Review 3.  Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis.

Authors:  Bradley N Gaynes; Stacey W Lloyd; Linda Lux; Gerald Gartlehner; Richard A Hansen; Shannon Brode; Daniel E Jonas; Tammeka Swinson Evans; Meera Viswanathan; Kathleen N Lohr
Journal:  J Clin Psychiatry       Date:  2014-05       Impact factor: 4.384

4.  A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.

Authors:  David L Dunner; Scott T Aaronson; Harold A Sackeim; Philip G Janicak; Linda L Carpenter; Terrence Boyadjis; David G Brock; Dafna Bonneh-Barkay; Ian A Cook; Karl Lanocha; H Brent Solvason; Mark A Demitrack
Journal:  J Clin Psychiatry       Date:  2014-12       Impact factor: 4.384

Review 5.  A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.

Authors:  David A Mrazek; John C Hornberger; C Anthony Altar; Irina Degtiar
Journal:  Psychiatr Serv       Date:  2014-08-01       Impact factor: 3.084

6.  Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.

Authors:  Linda L Carpenter; Philip G Janicak; Scott T Aaronson; Terrence Boyadjis; David G Brock; Ian A Cook; David L Dunner; Karl Lanocha; H Brent Solvason; Mark A Demitrack
Journal:  Depress Anxiety       Date:  2012-06-11       Impact factor: 6.505

7.  Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.

Authors:  Raphaëlle Richieri; Eric Guedj; Pierre Michel; Anderson Loundou; Pascal Auquier; Christophe Lançon; Laurent Boyer
Journal:  J Affect Disord       Date:  2013-06-18       Impact factor: 4.839

8.  Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.

Authors:  Philip G Janicak; Ziad Nahas; Sarah H Lisanby; H Brent Solvason; Shirlene M Sampson; William M McDonald; Lauren B Marangell; Peter Rosenquist; W Vaughn McCall; James Kimball; John P O'Reardon; Colleen Loo; Mustafa H Husain; Andrew Krystal; William Gilmer; Sheila M Dowd; Mark A Demitrack; Alan F Schatzberg
Journal:  Brain Stimul       Date:  2010-08-11       Impact factor: 8.955

Review 9.  Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.

Authors:  Robert M A Hirschfeld; Stuart A Montgomery; Eugenio Aguglia; Mario Amore; Pedro L Delgado; Markus Gastpar; Christopher Hawley; Siegfried Kasper; Michael Linden; Juan Massana; Julien Mendlewicz; Hans-Jürgen Möller; Charles B Nemeroff; Jerónimo Saiz; Pedro Such; Riccardo Torta; Marcio Versiani
Journal:  J Clin Psychiatry       Date:  2002-09       Impact factor: 4.384

Review 10.  The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.

Authors:  Tarique Perera; Mark S George; Geoffrey Grammer; Philip G Janicak; Alvaro Pascual-Leone; Theodore S Wirecki
Journal:  Brain Stimul       Date:  2016-03-16       Impact factor: 8.955
View more
  3 in total

1.  Second Courses of Transcranial Magnetic Stimulation (TMS) in Major Depressive Episodes for Initial Responders and Non-Responders.

Authors:  Saxby Pridmore; Sheila Erger; Tamara May
Journal:  Malays J Med Sci       Date:  2019-06-28

2.  Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment.

Authors:  Hannah Stirton; Benjamin P Meek; Andrea L Edel; Zahra Solati; Arun Surendran; Harold Aukema; Mandana Modirrousta; Amir Ravandi
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

3.  Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.

Authors:  Samuel Bulteau; Andrew Laurin; Christelle Volteau; Cécile Dert; Lydie Lagalice; Solène Schirr-Bonnans; Nicolas Bukowski; Marie Guitteny; Luc Simons; Clémence Cabelguen; Anne Pichot; Fabienne Tessier; Annabelle Bonnin; Adeline Lepage; Jean-Marie Vanelle; Anne Sauvaget; Valery-Pierre Riche
Journal:  Trials       Date:  2020-04-05       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.